Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fridkin

Showing results (61-70 of 515) with videos related to

Pageof 52
Sort By:
Peptides|October 6, 2001
N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activityH Tsubery, I Ofek, S Cohen, et al.
European Journal of Biochemistry|September 15, 1977
On the role of tryptophan in luteinizing-hormone-releasing hormone (luliberin)E Hazum, M Fridkin, R Meidan, et al.
Mechanisms of Ageing and Development|December 29, 2004
Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseasesMoussa B H Youdim, Mati Fridkin, Hailin Zheng
Biochemical and Biophysical Research Communications|March 28, 1986
Growth hormone releasing factor-like immunoreactivity in human milkH Werner, T Amarant, M Fridkin, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1986
Localization of growth hormone-releasing hormone in the human hypothalamus and pituitary stalkH Werner, E Okon, M Fridkin, et al.
Psychological Trauma : Theory, Research, Practice and Policy|April 4, 2017
The double-edged sword: The role of empathy in military veterans' partners distressRachel Dekel, Alana Siegel, Shimon Fridkin, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 14, 2004
Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseasesM B H Youdim, M Fridkin, H Zheng
Regulatory Peptides|September 12, 2006
Novel extended and branched N-terminal analogs of VIPDavid Dangoor, Sara Rubinraut, Mati Fridkin, et al.
Current Drug Targets|June 9, 2012
Novel chelators targeting cell cycle arrest, acetylcholinesterase, and monoamine oxidase for Alzheimer's therapyHailin Zheng, Mati Fridkin, Moussa B H Youdim
Journal of Medicinal Chemistry|August 24, 2000
Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteriaH Tsubery, I Ofek, S Cohen, et al.
Pageof 52

Showing results (61-70 of 515) with videos related to

Sort By:
Pageof 52
Peptides|October 6, 2001
N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activityH Tsubery, I Ofek, S Cohen, et al.
European Journal of Biochemistry|September 15, 1977
On the role of tryptophan in luteinizing-hormone-releasing hormone (luliberin)E Hazum, M Fridkin, R Meidan, et al.
Mechanisms of Ageing and Development|December 29, 2004
Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseasesMoussa B H Youdim, Mati Fridkin, Hailin Zheng
Biochemical and Biophysical Research Communications|March 28, 1986
Growth hormone releasing factor-like immunoreactivity in human milkH Werner, T Amarant, M Fridkin, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1986
Localization of growth hormone-releasing hormone in the human hypothalamus and pituitary stalkH Werner, E Okon, M Fridkin, et al.
Psychological Trauma : Theory, Research, Practice and Policy|April 4, 2017
The double-edged sword: The role of empathy in military veterans' partners distressRachel Dekel, Alana Siegel, Shimon Fridkin, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 14, 2004
Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseasesM B H Youdim, M Fridkin, H Zheng
Regulatory Peptides|September 12, 2006
Novel extended and branched N-terminal analogs of VIPDavid Dangoor, Sara Rubinraut, Mati Fridkin, et al.
Current Drug Targets|June 9, 2012
Novel chelators targeting cell cycle arrest, acetylcholinesterase, and monoamine oxidase for Alzheimer's therapyHailin Zheng, Mati Fridkin, Moussa B H Youdim
Journal of Medicinal Chemistry|August 24, 2000
Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteriaH Tsubery, I Ofek, S Cohen, et al.
Pageof 52